![Ben Shepherd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ben Shepherd
Chief Executive Officer at Trestle Biotherapeutics, Inc.
Profile
Ben Shepherd is the founder of Trestle Biotherapeutics, Inc. He held the title of Chief Executive Officer at the company, although he is no longer active in that role.
Ben Shepherd active positions
Companies | Position | Start |
---|---|---|
Trestle Biotherapeutics, Inc.
![]() Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Trestle Biotherapeutics, Inc.
![]() Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Ben Shepherd